MyAverix Finance
F · Healthcare
Dynavax Technologies Corporation (DYF1)
Drug Manufacturers - Specialty & Generic
Dynavax Technologies Corporation (DYF1) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-31, reported market cap is $1.63B, P/E ratio is 18.00, net margin is -13.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for DYF1
Dynavax Technologies Corporation (DYF1) — FAQ
What is Dynavax Technologies Corporation's market cap?
Dynavax Technologies Corporation (DYF1) has a reported market cap of $1.63B (data as of 2026-03-31).
What is DYF1's P/E ratio?
The price-to-earnings (P/E) ratio for Dynavax Technologies Corporation (DYF1) is 18.00 (data as of 2026-03-31).
Does Dynavax Technologies Corporation pay a dividend?
Dividend yield is not available in the current snapshot for Dynavax Technologies Corporation (DYF1). Check the MyAverix Finance app for the latest dividend data.
What sector is Dynavax Technologies Corporation in?
Dynavax Technologies Corporation (DYF1) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is DYF1 listed on?
DYF1 is listed on F.
What is Dynavax Technologies Corporation's net margin?
Dynavax Technologies Corporation (DYF1) reports a net margin of -13.1% (data as of 2026-03-31).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.